The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, GlucoTrack's share price is $0.225.
GlucoTrack's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00. Hence, GlucoTrack's PS Ratio for today is .
The historical rank and industry rank for GlucoTrack's PS Ratio or its related term are showing as below:
During the past 13 years, GlucoTrack's highest PS Ratio was 1433.82. The lowest was 0.32. And the median was 118.83.
GCTK's PS Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.015 * Ranked among companies with meaningful PS Ratio only.
During the past 13 years, GlucoTrack's highest 3-Year average Revenue per Share Growth Rate was 98.80% per year. The lowest was -77.50% per year. And the median was -41.50% per year.
Back to Basics: PS Ratio
GlucoTrack PS Ratio Historical Data
The historical data trend for GlucoTrack's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, GlucoTrack's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GlucoTrack's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GlucoTrack's PS Ratio distribution charts can be found below:
* The bar in red indicates where GlucoTrack's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
GlucoTrack's Share Price of today is $0.225. GlucoTrack's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
GlucoTrack PS Ratio Related Terms
Thank you for viewing the detailed overview of GlucoTrack's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GCTK has been successfully added to your 